Literature DB >> 17359632

Traditional Korean medicine: now and the future.

Kang-Hyun Leem1, Hun-Kuk Park.   

Abstract

BACKGROUND: The foundation of traditional Korean medicine (TKM) was originally set out in Korean mythology 5000 years ago. It has developed unique medical theories and methods to treat diseases including neurological disorders such as stroke, epilepsy and Parkinson's disease.
RESULTS: Main components of TKM consist of medicinal treatment, acupuncture and Sasang constitutional medicine. Among these, Sasang is a unique theory and has been used as a major treatment regimen in TKM. Recent studies of TKM have demonstrated therapeutic effects, underlying mechanism responsible for its effects and the relationship with genetic variations. Clinical and genetic studies about TKM have indicated linkage of TKM with pharmacogenomics.
CONCLUSION: In this special issue, four review articles about TKM, 10 original research and three clinical studies were presented. If modern medicine provides complement of TKM, it would open up new prospect of research and clinical regimen for various neurological diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17359632     DOI: 10.1179/016164107X172392

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  11 in total

1.  Sasang constitutional medicine and traditional chinese medicine: a comparative overview.

Authors:  Junghee Yoo; Euiju Lee; Chungmi Kim; Junhee Lee; Lao Lixing
Journal:  Evid Based Complement Alternat Med       Date:  2011-09-19       Impact factor: 2.629

2.  Constitutional multicenter bank linked to Sasang constitutional phenotypic data.

Authors:  Hee-Jeong Jin; Younghwa Baek; Ho-Seok Kim; Jonghyang Ryu; Siwoo Lee
Journal:  BMC Complement Altern Med       Date:  2015-03-10       Impact factor: 3.659

Review 3.  Personalized acupuncture treatment with Sasang typology.

Authors:  Han Chae; Jeongyun Lee; Eun Sang Jeon; Jae Kyu Kim
Journal:  Integr Med Res       Date:  2017-07-14

4.  Antioxidant and Anti-Inflammatory Effects of Herbal Formula SC-E3 in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages.

Authors:  Soo Chil Lee; Young-Won Kwon; Ju-Yeon Park; Sung Yun Park; Ju-Hee Lee; Sun-Dong Park
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-15       Impact factor: 2.629

5.  Genetic approach to elucidation of sasang constitutional medicine.

Authors:  Bu-Yeo Kim; Seongwon Cha; Hee-Jeong Jin; Sangkyun Jeong
Journal:  Evid Based Complement Alternat Med       Date:  2009-09       Impact factor: 2.629

6.  The anti-inflammatory effect of Indonesian Areca catechu leaf extract in vitro and in vivo.

Authors:  Kang Pa Lee; Giftania Wardani Sudjarwo; Ji-Su Kim; Septrianto Dirgantara; Won Jai Maeng; Heeok Hong
Journal:  Nutr Res Pract       Date:  2014-05-15       Impact factor: 1.926

7.  Translation of Korean Medicine Use to ICD-Codes Using National Health Insurance Service-National Sample Cohort.

Authors:  Ye-Seul Lee; Ye-Rin Lee; Younbyoung Chae; So-Youn Park; In-Hwan Oh; Bo-Hyoung Jang
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-16       Impact factor: 2.629

8.  A Pilot Study on Characteristics of Metabolomics and Lipidomics according to Sasang Constitution.

Authors:  Min Jung Kim; Da-Hye Lee; Jiyun Ahn; Tae-Youl Ha; Young Jin Jang; Eunju Do; Chang Hwa Jung
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-30       Impact factor: 2.629

9.  Vasorelaxant and Hypotensive Effects of Cheonwangbosimdan in SD and SHR Rats.

Authors:  Bumjung Kim; Cheolmin Jo; Ho-Young Choi; Kyungjin Lee
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-10       Impact factor: 2.629

Review 10.  Korean traditional foods as antiviral and respiratory disease prevention and treatments: A detailed review.

Authors:  Gitishree Das; J Basilio Heredia; Maria de Lourdes Pereira; Ericsson Coy-Barrera; Sonia Marlene Rodrigues Oliveira; Erick Paul Gutiérrez-Grijalva; Luis Angel Cabanillas-Bojórquez; Han-Seung Shin; Jayanta Kumar Patra
Journal:  Trends Food Sci Technol       Date:  2021-07-30       Impact factor: 12.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.